Apyx medical corporation to release third quarter of fiscal year 2025 financial results on november 6, 2025

Clearwater, fla., oct. 23, 2025 (globe newswire) -- apyx medical corporation (nasdaq: apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion® and the ayon body contouring system™, today announced that financial results for the third quarter of fiscal year 2025 will be released before markets open on thursday, november 6th.
APYX Ratings Summary
APYX Quant Ranking